22nd International AIDS Conference (AIDS 2018) held on July 23-27, 2018 at Amsterdam, Netherlands

  1. Acosta RK, White KL, Garner W, Wei X, Andreatta K, Willkom M, Kityo C, Avihingsanon A, Romanova S, Maggiolo F, Yazdanpanah Y, Orkin C, Rockstroh J, DeJesus E, SenGupta D, Makadzange T, Graham H, Martin H, and Quirk E. HIV-1 subtype (B or non-B) had no impact on the efficacy of B/F/TAF or resistance development in five phase 3 treatment-naïve or switch studies.
  2. Ananworanich J, Pinyakorn S, Avihingsanon A, Wongsabut J, Sacdalan C, Kroon E, Colby D, Trichavaroj R, de Souza M, Michael N, Robb ML, Phanuphak P, Phanuphak N on behalf of the RV254/SEARCH 010 and HIV-NAT 006 Study Groups. Favorable clinical phenotype reached in less than half of people treated in acute HIV infection.
  3. Apornpong T, Sookkasame N, Sakulrak S, Hiransuthikul A, Han WM, Gatechompol S, Wattanachanya L, Jamthong J, Kerr SJ, Sangarlangkarn A, Ruxrungtham K, Avihingsanon A, HIV-NAT 207 study team. Higher Prevalence of Insulin Resistance among non Diabetes HIV-infected Ageing Asian received long term ART compared to HIV uninfected Control. Poster number: TUPEB119
  4. Apornpong T, Sookkasame N, Sakulrak S, Hiransuthikul A, Han WM, Gatechompol S, Kerr SJ, Wattanachanya L, Ruxrungtham K, Avihingsanon A on behalf of HIV-NAT 207 study team. Triglycerides/glucose index is a simple and clinically useful surrogate for surrogate for insulin resistance among non-diabetic HIV-infected aging in Asia. Poster number: TUPEB116
  5. Aurpibul L, Sophonphan J, Sun LP, Ounchanum P, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Chettra K, Suwanlerk T, Malee K, Ananworanich J, Puthanakit T. HIV-related stigma associated with high depressive symptom scores among perinatally HIV-infected youths. Poster number: THPEB147
  6. Avihingsanon A, Siwamogsatham S, Chutinet A, Putcharoen O, Aponporng T, Hiransuthikul A, Gatechompol S, Han WM, Kerr SJ, Ruxrungtham K, HIV-NAT 207/HIV-NAT006 Study Team. Prevalence and risk factors associated with carotid plaque and intima-medial thickness in virologically suppressed HIV-infected Asians. Poster number : TUPEB101
  7. Do TC, Kerr SJ, Avihingsanon A, Suksawek S, Klungklang S, Ananworanich J, Reiss P, Wit F on behalf of the HIV-NAT 006 Cohort. Frailty is Associated with HIV and Female Gender in Asians over 50. Poster number: TUPEB134
  8. Gatechompol S, Sophonphan J, Kawkitinarong K, Suwanpimolkul G, Ubolyam S, Kerr SJ, Avihingsanon A, and Ruxrungtham K. Poor treatment outcome and higher mortality rate among TB/HIV co-infected patients compared to TB without HIV infected patients. Poster number: WEPEB073
  9. Han WM, Jiamsakul A, Kiertiburanakul S, Ng OT, Sim B, Sun LP, Nguyen KV, Choi JY, Lee MP, Wong WW, Kamarulzaman A, Kumarasamy N, Zhang F, Tanuma J, Do CD, Chaiwarith R, Merati TP, Yunihastuti E, Pujari S, Ditangco R, Khusuwan S, Ross J, Avihingsanon A. Incidence and risk factors for type 2 diabetes mellitus in HIV-positive adults in TAHOD. Poster number: TUPEB123
  10. Han WM, Apornpong T, Kerr SJ, Gatechompol S, Hiransuthikul A, Do TUbolyam S, Avihingsanon A, Ruxrungtham K, on behalf of HIV-NAT 006 team. CD4/CD8 ratio normalization and its determinants in long-term virologically suppressed HIV-infected Thais. Poster number: TUPEC156
  11. Hiransuthikul A, Sakulrak S, Apornpong T, Avihingsanon A, Jamthong J, Han WM, Gatechompol S, Kerr SJ, Sangarlangkarn A, Ruxrungtham K and HIV-NAT 207 study team. Higher prevalence of depression among aging HIV-positive compared to HIV-negative individuals (11/30). Poster number: TUPEB076
  12. Hiransuthikul A, Chutinet A, Vongsayan P,Samajarn J, Keadpudsa S, Apornpong T, Chan P, Gatechompol S, Han WM, Sangarlangkarn A, Ruxrungtham K, Avihingsanon A and HIV-NAT 006/HIV-NAT 207 study team. Higher prevalent NCI in aging HIV-infected women despite lower comorbidities than men. Poster number: TUPEB072
  13. Hiransuthikul A, Himmad K, Kerr S, Thammajaruk N, Pankam T, Janamnuaysook R, Mills S, Vannakit R, Phanuphak P, and Phanuphak N on behalf of the iFACT study team. Drug-drug interactions between the use of feminizing hormone therapy and pre-exposure prophylaxis among transgender women: the iFACT study.
  14. Jantarabenjakul W, Srisamer J, Theerawit T, Sophonphan J, Veeravigom M, Chonchaiya W, Puthanakit T, Ananworanich J, Jahanshad N, Thompson PM, Malee K, Pancharoen C on behalf of the DOET study. Neurodevelopmental and behavioral outcomes in perinatally HIV infected children who initiated antiretroviral therapy within 3 months of age.
  15. Kerr SJ , Puthanakit T, Thongpaibul K, Malee KM, Ly PS, Suwanlerk T, Sophonphan J, Kosalaraksa P, Ounchanum P, Aurpibul L, Kanjanavanit S, Ngampiyaskul C, Chettra K, Paul R, Ananworanich J, Mellins CA, The PREDICT Resilience Study Group. Increased risk of executive, working memory, and emotional-behavioral problems among virologically well-controlled perinatally HIV-infected adolescents in Thailand and Cambodia. Poster number: THPEB146
  16. Siefried KJ, Mao L, Riches S, Kerr S, Rule J, McAllister J, de Wit J, Carr A on behalf of the PAART study investigators. Failure of antiretroviral therapy (ART) in Australian adults is mainly due to ART toxicity.
  17. Teeraananchai S, Ruxrungtham K, Law MG, Avihingsanon A, Chaivooth S, Teeraratkul A, Bhakeecheep S, Ongwandee S, Thanprasertsuk S, Kerr SJ. Loss to follow-up and associated factors of patients through the National AIDS Program in Thailand. Poster number: TUPEE624
  18. Ubolyam S, Iampornsin T, Sophonphan J, Avihingsanon A, Suwanpimolkul G, Kawkitinarong K, Ananworanich J, Ruxrungtham K, Kelleher A, Cooper D. Performance of a simple flow cytometric assay in the diagnosis of active TB. Poster number: WEPEB042
  19. Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M, on behalf of the International Epidemiology Databases to Evaluate AIDS (IeDEA). Drug susceptibility testing, HIV-coinfection and outcomes in patients treated for tuberculosis in low- and middle-income settings. (oral abstract)